Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Matching cancer survivors to the right level of support

NCT ID NCT07830368

NEW Symptom relief Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers at the University of Hong Kong are evaluating a survivorship program that sorts cancer patients into moderate or high needs after treatment. People with moderate needs receive weekly or bi-weekly e-intervention videos on managing distress and weight, with peer volunteers or research assistants checking in. People with high needs receive a more intensive version. The study measures how many eligible patients get assessed and referred, whether staff and volunteers adopt the program, and how patients fare on symptom distress, weight, quality of life, and lifestyle habits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a need-based survivorship program with e-intervention videos and peer support
What this could lead to
If it works, this could give cancer clinics a practical way to match survivors to the right level of support after treatment, from self-help videos to more intensive help.
What could go wrong
This is an implementation study, not a test of whether the program itself cures or treats cancer. It may show that patients do not take up referrals, that staff cannot deliver the program as planned, or that benefits seen in one health system do not carry over to others.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Feb 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: (Cancer patients) * Chinese/English speaking adult cancer patients aged 18 years or older * Within three years post-treatment attending the specialized outpatient clinics for surveillance Exclusion Criteria: (Cancer patients) * Non-Chinese or non-English speaking * Childhood cancer survivors * More than three years post-treatment * and/or unable to provide informed consent Inclusion Criteria: (Peer volunteers) * Aged 18 years or older * Able to communicate in Chinese or English * Have lived experience as a cancer survivor or caregiver

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer survivorship

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • PYEH Department of Clinical Oncology

    RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital

    RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Obstetrics & Gynaecology

    RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Oncology

    RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Surgery

    RECRUITING

    Hong Kong, Hong Kong, 000, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.